# With Cannabis, Seniors Find Relief but Lack Clinical Oversight

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/cannabis-clinical-oversight-seniors-relief-safety/
> **Published:** 2026-03-23T10:09:24-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:41:49-04:00
> **Clinical Summary:** Explore cannabis clinical oversight seniors need to ensure safe therapeutic use and minimize drug interactions in older adults.

---

✦ New
CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely.
⚒ Cannabis News  |  CED Clinic
Geriatric MedicineDrug Interactions[Chronic Pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/)Clinical OversightPolypharmacy

Why This Matters

Seniors represent the fastest-growing cannabis user demographic, yet most lack adequate medical supervision when using cannabis therapeutically. This oversight gap creates significant safety risks, particularly regarding drug interactions and dosing protocols in a population already managing multiple medications.

Clinical Summary
The commentary highlights a critical gap in geriatric cannabis care: while older adults increasingly turn to cannabis for conditions like [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), insomnia, and inflammation, most receive minimal or no medical oversight. Seniors face unique pharmacokinetic considerations including altered metabolism, increased sensitivity to psychoactive effects, and complex polypharmacy interactions. Without proper medical guidance, this population may experience adverse effects or suboptimal therapeutic outcomes despite cannabis providing legitimate symptom relief.

Dr. Caplan’s Take

“I see this daily in practice — seniors arriving with shopping bags of cannabis products they’ve tried, often with good intentions but poor outcomes because nobody guided their approach medically. The solution isn’t restricting access; it’s integrating cannabis into comprehensive geriatric care with the same rigor we apply to any therapeutic intervention.”

Clinical Perspective
🧠 Clinicians should proactively discuss [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) with senior patients, as many won’t volunteer this information. Focus on drug interaction screening, starting with ultra-low doses, and establishing clear therapeutic goals. Consider referring to cannabis-experienced clinicians when therapeutic cannabis appears clinically appropriate but falls outside your comfort zone.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20With%20cannabis%2C%20seniors%20find%20relief%20but%20not%20enough%20oversight%20-%20The%20Boston%20Globe%20%40drcaplan&url=https%3A//www.bostonglobe.com/2026/03/23/opinion/letters-seniors-cannabis-oversight-integrated-care/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.bostonglobe.com/2026/03/23/opinion/letters-seniors-cannabis-oversight-integrated-care/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20With%20cannabis%2C%20seniors%20find%20relief%20but%20not%20enough%20oversight%20-%20The%20Boston%20Globe%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.bostonglobe.com/2026/03/23/opinion/letters-seniors-cannabis-oversight-integrated-care/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

📰 Source: [https://www.bostonglobe.com/2026/03/23/opinion/letters-seniors-cannabis-oversight-integrated-care/](https://www.bostonglobe.com/2026/03/23/opinion/letters-seniors-cannabis-oversight-integrated-care/)

Table of Contents

- [FAQ](#FAQ)[What makes this cannabis news clinically relevant?](#What_makes_this_cannabis_news_clinically_relevant)
- [Why is geriatric medicine specifically highlighted in this cannabis update?](#Why_is_geriatric_medicine_specifically_highlighted_in_this_cannabis_update)
- [What drug interaction concerns should clinicians be aware of with cannabis?](#What_drug_interaction_concerns_should_clinicians_be_aware_of_with_cannabis)
- [How does cannabis relate to chronic pain management in clinical practice?](#How_does_cannabis_relate_to_chronic_pain_management_in_clinical_practice)
- [What does “clinical oversight” mean in the context of medical cannabis?](#What_does_8220clinical_oversight8221_mean_in_the_context_of_medical_cannabis)
- [Related](#Related)

## FAQ

#### What makes this cannabis news clinically relevant?

This update has been rated as having “Notable Clinical Interest” with a clinical relevance score of #70. It represents emerging findings or policy developments that healthcare providers should monitor closely for potential impacts on [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/).

#### Why is geriatric medicine specifically highlighted in this cannabis update?

Older adults represent a growing demographic of [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) users who require special consideration due to age-related physiological changes. Geriatric patients may have altered drug metabolism and increased sensitivity to cannabis effects.

#### What drug interaction concerns should clinicians be aware of with cannabis?

Cannabis can interact with various medications through liver enzyme systems, particularly affecting drugs with narrow therapeutic windows. Healthcare providers need to monitor for potential interactions with blood thinners, seizure medications, and other commonly prescribed drugs in older adults.

#### How does cannabis relate to chronic pain management in clinical practice?

[Medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) is increasingly being considered as an alternative or adjunct therapy for chronic pain conditions. This is particularly relevant given the ongoing opioid crisis and the need for safer long-term pain management options.

#### What does “clinical oversight” mean in the context of medical cannabis?

Clinical oversight refers to the need for proper medical supervision when patients use cannabis for therapeutic purposes. This includes monitoring for efficacy, side effects, drug interactions, and ensuring appropriate dosing and administration methods.

{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “With cannabis, seniors find relief but not enough oversight – The Boston Globe”, “url”: “https://www.bostonglobe.com/2026/03/23/opinion/letters-seniors-cannabis-oversight-integrated-care/”, “datePublished”: “2026-03-23T06:27:21Z”, “about”: “cannabis seniors find relief but not”}

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Society – Cannabis use among older adults is rising rapidly—especially for chronic pain …](https://cedclinic.com/cannabis-use-drug-interactions-older-adults/)

Explore the increasing trend of [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) among older adults, focusing on [chronic pain management](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) and societal impacts.

[Read More](https://cedclinic.com/cannabis-use-drug-interactions-older-adults/)

[Seniors make up more than 25% of adult use cannabis market in Delaware](https://cedclinic.com/cannabis-drug-interactions-seniors-market-trends/)

Learn about the significant presence of seniors in the cannabis market and implications for clinical care and policy.

[Discover Insights](https://cedclinic.com/cannabis-drug-interactions-seniors-market-trends/)

[Seniors are already using cannabis – policy needs to catch up | GreenState](https://cedclinic.com/cannabis-use-in-seniors-policy-needs-to-catch-up/)

Understand the gap between senior cannabis use and current policies, highlighting the need for improved clinical oversight.

[Explore Policy Needs](https://cedclinic.com/cannabis-use-in-seniors-policy-needs-to-catch-up/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).